Hear firsthand from originators behind several Flagship-founded companies about what it takes to build a bioplatform, why agility and iteration are so critical in the early days and beyond, and why team culture is an essential component on these journeys into the unknown to deliver big leaps for human health. Watch the full discussion featuring Flagship General Partner Avak Kahvejian and Flagship Origination Partners Kyle Chiang, Molly Gibson, and Jake Rubens.
More from:
Human Health
Amanda Kay on a New Approach to Biopharma Partnerships
Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK
Pioneering Partnerships: Accelerating our Collaboration with Pfizer
Halting the Trajectory of Disease with Preemptive Health
AI in Action
